Form 4: Adaptive Biotechnologies Executive Sells Shares
Insider Transaction (Form 4)
Susan Bobulsky, Chief Commercial Officer, MRD of Adaptive Biotechnologies Corp, sold 1,875 shares of common stock on November 11, 2026 for $32.00 per share.
Summary
- Open-market sale: disposed of 1,875 Common Stock at $32.00 ($60,000) on November 11, 2026; holds 387,475 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $60,000 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Susan Bobulsky — Officer (Chief Commercial Officer, MRD)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-11 | Open-market sale | Common Stock | 1,875 | $32 | $60.0K | 387,475 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-11 | Open-market sale (1,875 shares) |
Keywords
insider transaction, Form 4, ADPT, Adaptive Biotechnologies Corp, bearish, Susan Bobulsky
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.